Prof Raymond Wong
Professorial Fellow
Department of Surgery
104 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
Using RNA-targeting CRISPR-Cas13 and engineered U1 systems to target ABCA4 splice variants in Stargardt disease
DOI: 10.1016/j.omtn.2025.1027892025
Journal article
Cell Counting and Cell Cycle Analysis of Simple Non-Cultured Endothelial Cell Injection (SNEC-I) Therapy: Characterization for Clinical Translation
DOI: 10.3390/cells141309862025
Journal article
Extent of genetic and epigenetic factor reprogramming via a single viral vector construct in deaf adult mice
DOI: 10.1016/j.heares.2024.1091702025
Journal article
Bronchoalveolar lavage fluid (BALF): Clinical applications for present and future
DOI: 10.59717/j.xinn-med.2025.1001152025
Journal article
Preface
2025
Book Chapter
Cellular Reprogramming to Stimulate Retina Regeneration
DOI: 10.1007/978-3-031-94101-6_122023
Research grants (other domestic)
Development of Innovative Cellular Reprogramming Technology Toward Neural Lineages
RECENT SCHOLARLY WORKS
2025
Journal article
Innovative dual-gene delivery platform using miR-124 and PD-1 via umbilical cord mesenchymal stem cells and exosome for glioblastoma therapy
DOI: 10.1186/s13046-025-03336-42024
Journal article
NMNAT2 is a druggable target to drive neuronal NAD production
DOI: 10.1038/s41467-024-50354-52024
Journal article
NOS3 regulates angiogenic potential of human induced pluripotent stem cell-derived endothelial cells
DOI: 10.1016/j.bbrep.2024.1018762024
Journal article
Correction to: NMNAT2 is a druggable target to drive neuronal NAD production (Nature Communications, (2024), 15, 1, (6256), 10.1038/s41467-024-50354-5)
DOI: 10.1038/s41467-024-52439-7
RECENT PROJECTS
2014
Internal Research Grant
Modeling Leber's Hereditary Optic Neuropathy Using Induced Pluripotent Stem Cells